financetom
Forex World Market Business Cryptocurrency Commodities MAP
financetom
Business
financetom
/
Business
/
Aurora Cannabis Up 0.25% In US Premarket As Launches First Domestically Grown Medical Cannabis Brand in Germany Under New Cultivation License
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Aurora Cannabis Up 0.25% In US Premarket As Launches First Domestically Grown Medical Cannabis Brand in Germany Under New Cultivation License
Jan 23, 2025 4:44 AM

07:18 AM EST, 01/23/2025 (MT Newswires) -- Aurora Cannabis Inc. ( ACB ) , the Canadian-based leading global medical cannabis company, was at last look up 0.25% in US premarket as it launched Thursday the company's first German-cultivated medical cannabis product, under the brand IndiMed.

The new brand is manufactured at Aurora's EU-GMP facility in Leuna, Germany.

ACB will release results for its third quarter 2025 on Wednesday, February 5, 2025.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Integra LifeSciences Completes Acquisition of Acclarent
Integra LifeSciences Completes Acquisition of Acclarent
Apr 1, 2024
04:51 PM EDT, 04/01/2024 (MT Newswires) -- Integra LifeSciences Holdings ( IART ) said Monday it has completed its acquisition of Acclarent from Johnson & Johnson ( JNJ ) MedTech company to enhance its position in the ear, nose and throat treatment market. In December, Integra agreed to acquire Acclarent for $275 million in cash. Price: 34.8, Change: +0.08, Percent...
 Biomarin Pharmaceutical Insider Sold Shares Worth $2,173,341, According to a Recent SEC Filing
Biomarin Pharmaceutical Insider Sold Shares Worth $2,173,341, According to a Recent SEC Filing
Apr 1, 2024
04:56 PM EDT, 04/01/2024 (MT Newswires) -- George Eric Davis, Executive Vice President, Chief Legal Officer, on March 28, 2024, sold 24,602 shares in Biomarin Pharmaceutical ( BMRN ) for $2,173,341. Following the Form 4 filing with the SEC, Davis has control over a total of 55,856 shares of the company, with 55,856 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1048477/000104847724000054/xslF345X03/wk-form4_1712004839.xml ...
 AST SpaceMobile Q4 Net Loss Widens; Shares Decline
AST SpaceMobile Q4 Net Loss Widens; Shares Decline
Apr 1, 2024
04:57 PM EDT, 04/01/2024 (MT Newswires) -- AST SpaceMobile ( ASTS ) reported a Q4 net loss Monday of $0.35 per diluted share, widening from a loss of $0.14 a year earlier. Two analysts polled by Capital IQ expected $0.24. No revenue for the quarter ended Dec. 31 was reported. Two analysts surveyed by Capital IQ expected no revenue for...
 Canoo raises doubts about its ability to continue as a going concern
Canoo raises doubts about its ability to continue as a going concern
Apr 1, 2024
April 1 (Reuters) - Canoo Inc ( GOEV ) said on Monday there was substantial doubt about its ability to continue as a going concern. (Reporting by Granth Vanaik in Bengaluru) ...
About
Terms and Conditions Privacy policy Cookie Settings Contact Us
Services
Login register
financetom Market Personal Finance Business Economy Cryptocurrency MAP
Links
zpostcode Recruit weather mreligion Yellowpages sport constellation shopping name game directory literature Word tour furnish Lottery tftnews lyrics News digital car dir Edu Finance
Copyright 2023-2026 - www.financetom.com All Rights Reserved